RET-AVIT GEL 0.05 % Israel - English - Ministry of Health

ret-avit gel 0.05 %

cts chemical industries ltd, israel - tretinoin - gel - tretinoin 0.05 %w/w - tretinoin - tretinoin - treatment acne vulgaris.

RET-AVIT CREAM 0.05 % Israel - English - Ministry of Health

ret-avit cream 0.05 %

cts chemical industries ltd, israel - tretinoin - cream - tretinoin 0.05 %w/w - tretinoin - tretinoin - acne vulgaris.

RET-AVIT CREAM 0.025 % Israel - English - Ministry of Health

ret-avit cream 0.025 %

cts chemical industries ltd, israel - tretinoin - cream - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.

RET-AVIT GEL 0.025 % Israel - English - Ministry of Health

ret-avit gel 0.025 %

cts chemical industries ltd, israel - tretinoin - gel - tretinoin 0.025 %w/w - tretinoin - tretinoin - treatment of acne vulgaris.

AKNEMYCIN PLUS Israel - English - Ministry of Health

aknemycin plus

neopharm ltd - erythromycin; tretinoin - solution - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

Glivec Film Coated Tablet 100mg Singapore - English - HSA (Health Sciences Authority)

glivec film coated tablet 100mg

novartis (singapore) pte ltd - imatinib mesylate 119.5 mg eqv imatinib base - tablet, film coated - 100 mg - imatinib mesylate 119.5 mg eqv imatinib base 100 mg

Glivec Film Coated Tablet 400mg Singapore - English - HSA (Health Sciences Authority)

glivec film coated tablet 400mg

novartis (singapore) pte ltd - imatinib mesylate eqv imatinib base - tablet, film coated - 478.00 mg eqv. 400mg imatinib base - imatinib mesylate eqv imatinib base 400 mg

Intrinsa European Union - English - EMA (European Medicines Agency)

intrinsa

warner chilcott uk ltd. - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - intrinsa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.

Livensa European Union - English - EMA (European Medicines Agency)

livensa

warner chilcott  deutschland gmbh - testosterone - sexual dysfunctions, psychological - sex hormones and modulators of the genital system, - livensa is indicated for the treatment of hypoactive sexual desire disorder (hsdd) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.